Agalsidase beta treatment slows estimated glomerular filtration rate loss in classic Fabry disease patients: results from an individual patient data meta-analysis

BACKGROUND: Fabry disease is a rare, X-linked genetic disorder that, if untreated in patients with the Classic phenotype, often progresses to end-stage kidney disease. This meta-analysis determined the effect of agalsidase beta on loss of estimated glomerular filtration rate (eGFR) in the Classic ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Ortiz, Alberto, Kanters, Steve, Hamed, Alaa, DasMahapatra, Pronabesh, Poggio, Eugene, Maski, Manish, Aguiar, Mario, Ponce, Elvira, Jansen, Jeroen P, Ayers, Dieter, Goldgrub, Rachel, Desnick, Robert J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023189/
https://www.ncbi.nlm.nih.gov/pubmed/33841859
http://dx.doi.org/10.1093/ckj/sfaa065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023189/
https://www.ncbi.nlm.nih.gov/pubmed/33841859
http://dx.doi.org/10.1093/ckj/sfaa065

Ejemplares similares